People: Bruker Corp (BRKR.OQ)
19 Jul 2019
Mr. Gerald N. Herman is Chief Financial Officer Officer of the Company. Mr. Herman has served as our Chief Financial Officer since June 2018, after being named Interim Chief Financial Officer in March 2018. Mr. Herman joined Bruker in 2016 as Vice President and Corporate Controller. Prior to joining Bruker, Mr. Herman had served in senior executive positions with various publicly traded companies, including as Corporate Vice President—Clinical Operations of PAREXEL International from 2014 to February 2016, and as Corporate Vice President & Controller-Finance of PAREXEL from 2008 to 2013. Prior to 2008, Mr. Herman was Vice President—Corporate Controller of Presstek, Inc. He also served in financial, consulting and accounting roles at various organizations, including as Senior Manager at Arthur Andersen LLP from 1979 to 1987. Mr. Herman is a Certified Public Accountant (CPA) and holds a Master of Business Administration degree from the University of Chicago, and a Master of Science in Taxation from Bentley University.
|Total Annual Compensation, USD||360,939|
|Restricted Stock Award, USD||352,515|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||313,067|
|Fiscal Year Total, USD||1,026,520|